Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiming Lai

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Medcomm|February 14, 2025
SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasisChen Tang, Shengmeng Peng, Yongming Chen, et al.
Urologic Oncology|June 16, 2018
Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progressionShengmeng Peng, Tao Du, Wanhua Wu, et al.
The Prostate|February 24, 2017
Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient SurvivalsHai Huang, Tao Du, Yiming Zhang, et al.
Cell & Bioscience|November 16, 2023
The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatmentBisheng Cheng, Lingfeng Li, Yongxin Wu, et al.
The Prostate|January 23, 2018
Matrine inhibits the progression of prostate cancer by promoting expression of GADD45BHai Huang, Qiong Wang, Tao Du, et al.
Nature Communications|July 26, 2024
Room-temperature quantum nanoplasmonic coherent perfect absorptionYiming Lai, Daniel D A Clarke, Philipp Grimm, et al.
Medical Oncology (Northwood, London, England)|January 1, 2015
SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathwayJin Li, Yiming Lai, Yi Cao, et al.
Cancer Pathogenesis and Therapy|January 28, 2025
Integrative analysis of cuproptosis-related lncRNAs: Unveiling prognostic significance, immune microenvironment, and copper-induced mechanisms in prostate cancerHaitao Zhong, Yiming Lai, Wenhao Ouyang, et al.
Medical Oncology (Northwood, London, England)|July 31, 2021
Correction to: SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathwayJin Li, Yiming Lai, Yi Cao, et al.
Journal for Immunotherapy of Cancer|August 21, 2021
B7 score and T cell infiltration stratify immune status in prostate cancerQianghua Zhou, Kaiwen Li, Yiming Lai, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Medcomm|February 14, 2025
SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasisChen Tang, Shengmeng Peng, Yongming Chen, et al.
Urologic Oncology|June 16, 2018
Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progressionShengmeng Peng, Tao Du, Wanhua Wu, et al.
The Prostate|February 24, 2017
Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient SurvivalsHai Huang, Tao Du, Yiming Zhang, et al.
Cell & Bioscience|November 16, 2023
The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatmentBisheng Cheng, Lingfeng Li, Yongxin Wu, et al.
The Prostate|January 23, 2018
Matrine inhibits the progression of prostate cancer by promoting expression of GADD45BHai Huang, Qiong Wang, Tao Du, et al.
Nature Communications|July 26, 2024
Room-temperature quantum nanoplasmonic coherent perfect absorptionYiming Lai, Daniel D A Clarke, Philipp Grimm, et al.
Medical Oncology (Northwood, London, England)|January 1, 2015
SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathwayJin Li, Yiming Lai, Yi Cao, et al.
Cancer Pathogenesis and Therapy|January 28, 2025
Integrative analysis of cuproptosis-related lncRNAs: Unveiling prognostic significance, immune microenvironment, and copper-induced mechanisms in prostate cancerHaitao Zhong, Yiming Lai, Wenhao Ouyang, et al.
Medical Oncology (Northwood, London, England)|July 31, 2021
Correction to: SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathwayJin Li, Yiming Lai, Yi Cao, et al.
Journal for Immunotherapy of Cancer|August 21, 2021
B7 score and T cell infiltration stratify immune status in prostate cancerQianghua Zhou, Kaiwen Li, Yiming Lai, et al.
Pageof 6